875. Deputy Catherine Connolly asked the Minister for Health the engagement he or the HSE has had with a company (details supplied) with a view to resolving the ongoing exclusion of a cohort of 35 children with certain genotypes from access to the cystic fibrosis modular drug therapy, kaftrio; the details of any engagement he has had with cystic fibrosis advocacy groups in 2022 with regard to this issue; and if he will make a statement on the matter. [36241/22]

Summary

875. Deputy Catherine Connolly asked the Minister for Health the engagement he or the HSE has had with a company (details supplied) with a view to resolving the ongoing exclusion of a cohort of 35 children with certain genotypes from access to the cystic fibrosis modular drug therapy, kaftrio; the details of any engagement he has had with cystic fibrosis advocacy groups in 2022 with regard to this issue; and if he will make a statement on the matter. [36241/22]

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

1 official file

• Medicinal Products

  xml · EN · 5 July 2022

  ViewDownloadOpen at official source

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.